Shari Mitchell, Regional Director, Access and Reimbursement at Madrigal Pharmaceuticals, is a seasoned leader in BioPharma Access & Reimbursement with extensive expertise in healthcare strategy, payer access, and managed markets. With over two decades of experience, she has successfully built and led multiple field access teams, driving innovative patient support programs and access solutions across the industry. Currently serving as Regional Director of Access & Reimbursement at Madrigal, she plays a pivotal role in ensuring patient access to critical therapies. Her career includes leadership roles at Novartis and Genentech, where she developed and executed access strategies for immunology, ophthalmology, oncology, and cardiovascular products. A University of Florida graduate, Shari is recognized for her leadership, collaboration, and commitment to improving patient care.